Herd Immunity to Fight Against COVID-19: A Narrative Review

Area of Science:

• Virology and Immunology
• Public Health and Epidemiology
• Vaccinology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global pandemic with significant mortality and morbidity.
• Herd immunity, achieved through widespread vaccination, is a key strategy to mitigate the impact of contagious diseases like COVID-19.
• The global spread and high case/death counts underscore the urgent need for effective control measures.

Purpose of the Study:

• To review the fundamental concepts of herd immunity in the context of COVID-19.
• To discuss the benefits of herd immunity for reducing infection severity and protecting high-risk groups.
• To identify and analyze the obstacles hindering the achievement of herd immunity against SARS-CoV-2.

Main Methods:

• Literature review and conceptual analysis of herd immunity principles.
• Discussion of vaccination strategies and their role in achieving population-level immunity.
• Examination of challenges posed by viral evolution and new SARS-CoV-2 variants.

Main Results:

• Herd immunity offers substantial benefits, including protection for immunocompromised individuals, the elderly, and those with chronic conditions.
• Vaccination is the primary method for developing herd immunity and controlling the pandemic.
• Viral mutations, new strains, and uncertainties regarding vaccine efficacy duration pose significant challenges.

Conclusions:

• Achieving herd immunity is vital for managing COVID-19 reinfections and protecting vulnerable populations.
• Ongoing research is necessary to understand the impact of new variants, optimal vaccination schedules, and the duration of immunity.
• Addressing challenges related to viral evolution and vaccine effectiveness is critical for long-term pandemic control.